- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06151145
Stepped Care for Weight Loss Maintenance
This study is a 3-group, parallel design, randomized controlled trial (RCT) in approximately 258 adults with obesity that will investigate whether a 16-week behavioral weight loss treatment and a 52-week stepped-care digital health intervention can improve the maintenance of a ≥ 5% weight loss.
16-week run-in (Phase 1). To qualify for randomization, participants must lose ≥ 5% of initial weight in the 16-week run-in. This loss will be achieved with the provision of weekly-group lifestyle counseling, which includes a partial meal replacement diet.
52-week randomized trial of 3 weight loss maintenance strategies (Phase 2): Participants who have achieved ≥ 5% weight loss during Phase 1 will be randomly assigned to 1 of 3 groups:
- Participants in the Usual Care group will be emailed monthly educational modules with information on maintaining weight loss.
- Participants in the SELF group will receive a wireless "smart" body weight scale and a wearable physical activity tracker, and daily text messages with tailored feedback to assist in weight loss maintenance.
- Participants in the STEP group will be enrolled in an intervention that consists of 4 steps that are progressive and based on response to treatment. After 13 weeks at each step, participants who do not maintain a ≥5% weight loss or regain 2 percentage points of weight from the participants randomization value will move to a higher intensity step. Participants who maintain weight loss will stay at the same step.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI>/=30 kg/m2 or >/=27 kg/m2 with an obesity-related complication
- Age 18-70 years
- Completion of baseline assessment tasks
- Ability to engage in physical activity
- Own a smartphone capable of receiving text-messages and syncing to weight scales and physical activity trackers
- Home wireless access
Exclusion Criteria:
- Serious medical condition or psychiatric condition that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to adhere to the behavioral recommendations of the program
- Pregnant or planning pregnancy in the next 1.5 years
- Weight>440 lbs
- Planned move out of the area in the next 1.5 years
- Recently began a course of or changed the dosage of medication that can cause significant change in weight
- History of bariatric surgery
- Weight loss of >5% in the previous 6 months
- Household member already participating in study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual care
|
Participants in usual care will be emailed monthly educational modules with information on maintaining weight loss.
|
|
Experimental: Text-message intervention with digital tools (SELF)
Text-message intervention
|
The SELF group will receive a wireless "smart" body weight scale and wearable physical activity tracker, and text messages.
|
|
Experimental: Stepped Care (STEP)
Stepped care
|
The STEP intervention consists of 4 steps that are progressive and based on response to treatment.
Step 1: Digital health intervention.
The first step will be the digital health intervention as described under SELF.
Step 2: Monthly, in-person counseling.
Participants who move to Step 2 will be provided with monthly, in-person counseling.
Step 3: Twice per month counseling.
Step 3 will be twice-monthly counseling, spaced at every other week.
Step 4: Meal replacements.
Participants will be prescribed a partial meal replacement program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight (kg) change for STEP versus usual care
Time Frame: Baseline, 52 weeks
|
Weight change (kg) for STEP versus usual care
|
Baseline, 52 weeks
|
|
Weight (kg) change for SELF versus usual care
Time Frame: Baseline, 52 weeks
|
Weight change (kg) for SELF versus usual care
|
Baseline, 52 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in self-weighing frequency (days) for STEP and SELF versus usual care
Time Frame: Baseline, 52 weeks
|
Change in number of days of self-weighing for STEP and SELF versus usual care
|
Baseline, 52 weeks
|
|
Change in daily calorie intake for STEP and SELF vs usual care
Time Frame: Baseline, 52 weeks
|
Change in daily calorie intake measured using 24-hour dietary recalls for STEP and SELF versus usual care
|
Baseline, 52 weeks
|
|
Change in physical activity (minutes) for STEP and SELF versus usual care
Time Frame: Baseline, 52 weeks
|
Change in self-reported minutes of physical activity for STEP and SELF versus usual care
|
Baseline, 52 weeks
|
|
Weight (kg) change for STEP versus SELF
Time Frame: Baseline, 52 weeks
|
Weight change (kg) for STEP versus SELF
|
Baseline, 52 weeks
|
|
Change in days of self-weighing for STEP versus SELF
Time Frame: Baseline, 52 weeks
|
Self-weighing frequency for STEP versus SELF
|
Baseline, 52 weeks
|
|
Change in daily calorie intake for STEP versus SELF
Time Frame: Baseline, 52 weeks
|
Change in daily calorie intake measured using 24-hour dietary recalls for STEP versus SELF
|
Baseline, 52 weeks
|
|
Change in self-reported minutes of Physical activity for STEP versus SELF
Time Frame: Baseline, 52 weeks
|
Change in self-reported minutes of physical activity for STEP versus SELF
|
Baseline, 52 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost effectiveness
Time Frame: Up to 52 weeks
|
To evaluate the incremental cost effectiveness per unit decrease in weight (kg) from a healthcare payer perspective
|
Up to 52 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ariana M Chao, PhD, CRNP, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00404188
- R01NR020197 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Usual care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
Centers for Disease Control and PreventionCompleted
-
Parc de Salut MarCompleted
-
Cairo UniversityCompletedChronic Obstructive Lung DiseaseEgypt